Suppr超能文献

类噻嗪利尿剂吲达帕胺对高血压大鼠脑小动脉结构的影响。

Effects of indapamide, a thiazide-like diuretic, on structure of cerebral arterioles in hypertensive rats.

作者信息

Chillon Jean-Marc, Baumbach Gary L

机构信息

Laboratory of Cardiovascular Pharmacology, Faculty of Pharmacy, University Henri Poincaré-Nancy, France.

出版信息

Hypertension. 2004 May;43(5):1092-7. doi: 10.1161/01.HYP.0000122874.21730.81. Epub 2004 Mar 8.

Abstract

We examined the effects of indapamide, a thiazide-like diuretic, on cerebral arterioles in spontaneously hypertensive rats (SHR). The structure and mechanics of cerebral arterioles were examined in untreated Wistar Kyoto rats (WKY) and SHR that were untreated or treated for 3 months with a low (1 mg/kg per day) or a high (10 mg/kg per day) dose of indapamide. We measured pressure, diameter, and cross-sectional area of the vessel wall (CSA) in maximally-dilated (EDTA) cerebral arterioles. Treatment of SHR with the high dose of indapamide normalized cerebral arteriolar mean pressure (62+/-4 [mean+/-SEM] versus 59+/-3 mm Hg in WKY and 88+/-6 mm Hg in untreated SHR; P<0.05), pulse pressure (13+/-1 versus 10+/-1 mm Hg in WKY and 20+/-1 mm Hg in untreated SHR; P<0.05), and CSA (1080+/-91 versus 1100+/-48 microm2 in WKY and 1439+/-40 microm2 in untreated SHR; P<0.05). In contrast, treatment of SHR with the low dose of indapamide did not normalize arteriolar mean (72+/-3) and pulse pressure (20+/-1 mm Hg), but did normalize CSA (1091+/-52 microm2). Treatment with either dose of indapamide failed to increase external diameter in cerebral arterioles of SHR (89+/-4 and 92+/-4 microm, respectively, versus 103+/-6 microm in WKY and 87+/-4 microm in untreated SHR). Finally, treatment with indapamide attenuated the rightward shift of the stress-strain curve in SHR, suggesting that treatment with indapamide attenuated increases in distensibility of cerebral arterioles in SHR. These findings suggest that, whereas thiazide-like diuretics may not attenuate eutrophic inward remodeling of cerebral arterioles in SHR, they may attenuate hypertrophic inward remodeling via a mechanism unrelated to their pressor effects.

摘要

我们研究了类噻嗪利尿剂吲达帕胺对自发性高血压大鼠(SHR)脑小动脉的影响。在未治疗的Wistar Kyoto大鼠(WKY)以及未治疗或用低剂量(每天1 mg/kg)或高剂量(每天10 mg/kg)吲达帕胺治疗3个月的SHR中,检测了脑小动脉的结构和力学性能。我们测量了最大扩张(EDTA)状态下脑小动脉的压力、直径和血管壁横截面积(CSA)。高剂量吲达帕胺治疗SHR可使脑小动脉平均压力正常化(WKY为62±4 [平均值±标准误],未治疗的SHR为88±6 mmHg,治疗后为59±3 mmHg;P<0.05)、脉压正常化(WKY为13±1,未治疗的SHR为20±1 mmHg,治疗后为10±1 mmHg;P<0.05)以及CSA正常化(WKY为1080±91,未治疗的SHR为1439±40 µm²,治疗后为1100±48 µm²;P<0.05)。相比之下,低剂量吲达帕胺治疗SHR虽未使小动脉平均压(72±3)和脉压(20±1 mmHg)正常化,但使CSA正常化(1091±52 µm²)。两种剂量的吲达帕胺治疗均未能增加SHR脑小动脉的外径(分别为89±4和92±4 µm,而WKY为103±6 µm,未治疗的SHR为87±4 µm)。最后,吲达帕胺治疗减弱了SHR应力-应变曲线的右移,表明吲达帕胺治疗减弱了SHR脑小动脉扩张性的增加。这些发现表明,虽然类噻嗪利尿剂可能不会减弱SHR脑小动脉的营养性内向重塑,但它们可能通过一种与其升压作用无关的机制减弱肥厚性内向重塑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验